Shares of Axonics, Inc. (NASDAQ:AXNX – Get Rating) have earned a consensus rating of “Moderate Buy” from the nine analysts that are currently covering the stock, MarketBeat reports. One analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. The average 12-month price objective among brokers […]
Sectoral Asset Management Inc. lessened its holdings in Axonics, Inc. (NASDAQ:AXNX – Get Rating) by 23.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 87,646 shares of the company’s stock after selling 26,650 shares during the quarter. Sectoral […]
Jennison Associates LLC lessened its holdings in shares of Axonics, Inc. (NASDAQ:AXNX – Get Rating) by 39.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 200,083 shares of the company’s stock after selling 128,460 shares during the quarter. Jennison […]
Arcadia Investment Management Corp MI acquired a new stake in Axonics, Inc. (NASDAQ:AXNX – Get Rating) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 1,211 shares of the company’s stock, valued at approximately $76,000. Several other institutional investors have also […]
Axonics (NASDAQ:AXNX – Get Rating) released its earnings results on Tuesday. The company reported ($0.19) EPS for the quarter, topping the consensus estimate of ($0.29) by $0.10, Briefing.com reports. Axonics had a negative return on equity of 11.82% and a negative net margin of 21.81%. The business had revenue of $70.65 million during the quarter, […]